Skip to main content

Advertisement

Table 3 Results of univariate analysis of overall survival in patients with mCRC

From: Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: results from mCRC biomarker study

Variables Hazard ratio 95%CI P-value
Age (years) (≥ 65 versus < 65) 0.918 0.56–1.261 0.400
Gender 1.432 1.037–1.977 0.029
MPV (≥ 9.75 fL versus < 9.75 fL) 1.398 1.005–1.946 0.047
WBC 1.082 1.018–1.150 0.011
ANC 1.084 1.016–1.157 0.015
Lymphocyte 0.861 0.64–1.157 0.320
Hemoglobin (≤120 × 109/L vs.>120 × 109/L) 0.630 0.453–0.87 0.006
PLT 1.002 1–1.003 0.018
PCT 4.234 1.17–15.322 0.028
PDW 0.961 0.901–1.026 0.234
PLR 1.003 1–1.004 0.002
NLR 1.066 1.007–1.128 0.028
Efficacy 1.529 1.285–1.820 0.000
  1. Abbreviation: see Table 1 and Table 2